Study of nafenopin, a hypolipidemic drug on liver metabolism.
Gerbracht
U
U
Inst of Vet. Biochemistry, Univ. of Giessen, FRG.
Köpf
G
G
Wüst
G
G
Weisse
G
G
Schlatterer
B
B
Eigenbrodt
E
E
D000818:Animals; D050260:Carbohydrate Metabolism; D004032:Diet; D004789:Enzyme Activation / Q000187:drug effects; D005223:Fats / Q000378:metabolism; D005260:Female; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D009255:Nafenopin / Q000494:pharmacology*; D010743:Phospholipids / Q000378:metabolism; D011422:Propionates / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D013194:Staining and Labeling
D005223:Fats; D000960:Hypolipidemic Agents; D010743:Phospholipids; D011422:Propionates; D009255:Nafenopin